Company intelligence / Profile preview

Serum Institute of India

Pune, Maharashtra, Indiaseruminstitute.com ↗
Ownership
Private
Employees
~7000
Development stage
Commercial
01

Overview

Serum Institute of India manufactures over three billion doses annually across more than two dozen WHO-prequalified vaccines covering all major childhood immunizations and several adult/preventive indications. Its products are widely used in global immunization programs run by WHO/UNICEF/PAHO/GAVI. The company played a pivotal role during the COVID‑19 pandemic with Covishield™—the Oxford/AstraZeneca vaccine manufactured under license—and continues to expand its portfolio with new launches such as R21 malaria vaccine and indigenous HPV vaccine Cervavac.

Therapeutic areas
OtherOncologyInfectious Diseases
Modalities
Vaccines (recombinant, conjugate, live attenuated, inactivated)Monoclonal antibodies (e.g., Rabies Human Monoclonal Antibody)Antisera
Industry
Pharma
02

Drug pipeline

63 assets

meningococcal A conjugate vaccine

Approved

62 more assets in the full pipeline.

03

Partnerships

University of Oxford/AstraZeneca/Covax for COVID‑19 vaccine production (“Covishield”)CEPI partnership for rapid outbreak response/vaccine development networkPATH/MenAfriVac project/Bill & Melinda Gates Foundation/National Institutes of Health on various affordable global health vaccinesUNICEF/GAVI supply partnerships

Beyond the preview

Go deeper on Serum Institute of India.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum Institute of India.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call